MedTrace Logo

Multimodal Spectroscopy (MMS) for in Vivo Noninvasive Assessment of Skin

NCT02704039 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 239

Last updated 2019-03-13

No results posted yet for this study

Summary

The goal of this research program is to develop a simple, noninvasive diagnostic device for assessing skin pathology without the need for a biopsy. The device being studied is a single system capable of collecting three spectroscopy measurements (Raman, diffuse reflectance and laser induced fluorescence spectroscopy) from skin lesion sites. In order to accomplish this objective, the investigators propose to: 1) develop biophysical model for Raman spectroscopy of skin cancers, 2) conduct a clinical pilot study to collect MMS data from a minimum of 250 patients to determine the diagnostic accuracy (sensitivity and specificity) of MMS for diagnosing skin malignancy.

Conditions

Sponsors & Collaborators

  • Seton Healthcare Family

    collaborator OTHER

  • Cancer Prevention Research Institute of Texas

    collaborator OTHER

  • University of Texas at Austin

    lead OTHER

Principal Investigators

  • James Tunnell, PhD · University of Texas at Austin

  • Jason Reichenberg, MD · Seton & The University of Texas at Austin Dell Medical School

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2017-08-31
Completion
2018-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02704039 on ClinicalTrials.gov